Clinical Trials on Follicular Lymphoma (FL/Indolent NHL)
Total 1013 results
-
M.D. Anderson Cancer CenterGenentech, Inc.; BiogenCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminated
-
Boehringer IngelheimCompletedLymphoma, FollicularSpain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
-
Lymphoma Study AssociationCompletedLymphoma, FollicularFrance, Italy
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedLymphoma, FollicularHungary
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
CelgeneNot yet recruitingLymphoma, FollicularUnited States, Australia, Brazil, Canada, Chile, France, Germany, Italy, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
Eisai Co., Ltd.Recruiting
-
Xynomic Pharmaceuticals, Inc.Recruiting
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Hoffmann-La RocheCompletedLymphoma, FollicularFrance, United States
-
Bristol-Myers SquibbCompletedLymphomaAustralia, Italy, United States, Spain, Canada, United Kingdom, Germany, Belgium, France, Singapore, Sweden, Norway
-
Incyte CorporationCompletedLymphomaSpain, Hungary, United States, Denmark, Italy, Czechia
-
Dartmouth-Hitchcock Medical CenterSpectrum Pharmaceuticals, Inc; CephalonCompletedLymphoma, FollicularUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
Archigen Biotech LimitedCompletedLymphoma, FollicularUnited States, Korea, Republic of, Hungary, Spain, Turkey, Czechia, Italy, France, United Kingdom, Germany, South Africa, Australia, Chile, Mexico
-
Eli Lilly and CompanyCompletedLymphoma, FollicularUnited States, Germany
-
Hoffmann-La RocheCompletedLymphoma, FollicularSerbia
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, Australia, France, Poland, United Kingdom, Spain, Belgium, Germany, Russian Federation
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Boehringer IngelheimTerminatedLymphoma, Non-HodgkinAustria, Belgium, United States, Bulgaria, Croatia, Czech Republic
-
GlaxoSmithKlineWithdrawnLymphoma, FollicularUnited States
-
GlaxoSmithKlineCompletedLymphoma, FollicularUnited States
-
Janssen-Cilag G.m.b.HTerminated
-
Commissie Voor Klinisch Toegepast OnderzoekEuropean Organisation for Research and Treatment of Cancer - EORTCUnknownLymphomaFrance, Netherlands, Belgium
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaUnited States, United Kingdom, Italy, Germany, Poland, France
-
Xinqiao Hospital of ChongqingXuzhou Medical UniversityUnknownRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Stage III/IV Adult Diffuse Large Cell Lymphoma | Stage III/IV Follicular Lymphoma | Stage III/IV Mantle Cell LymphomaChina
-
Hospices Civils de LyonUnknownFollicular Lymphoma | Genetic Predisposition to DiseaseFrance
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
Oslo University HospitalAarhus University Hospital; Hoffmann-La RocheRecruitingLymphoma, FollicularNorway, Finland
-
Incyte Biosciences Japan GKCompleted
-
SecuraBioWithdrawn
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheTerminatedLymphoma, FollicularGreece
-
Hoffmann-La RocheCompletedLymphoma, FollicularSpain, Sweden, Canada, Mexico, Czech Republic, France, Switzerland, Australia, Israel, Korea, Republic of, United Kingdom, Italy, Brazil, Finland, Russian Federation, Peru, Denmark, Argentina, Poland, Ecuador, Norway, Slovakia
-
Gemin XCompleted
-
M.D. Anderson Cancer CenterCureTech LtdCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Duke UniversityMillennium Pharmaceuticals, Inc.TerminatedLymphoma, FollicularUnited States
-
Icon Genetics GmbHCompleted
-
GlaxoSmithKlineCompletedLymphoma, FollicularUnited Kingdom
-
Lymphoma Study AssociationCompletedLymphomaFrance, Belgium
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma and other conditionsUnited States
-
Rush University Medical CenterGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated